The disposition of pravastatin in a rat model of streptozotocin-induced diabetes and organic anion transporting polypeptide 2 and multidrug resistance-associated protein 2 expression in the liver.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/BPB.33.153PMID 20045956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis

  2008cited by this paper
• Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis.

  2008cited by this paper
• Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.

  2006cited by this paper
• DISPOSITION OF ORAL AND INTRAVENOUS PRAVASTATIN IN MRP2-DEFICIENT TR– RATS

  2005cited by this paper
• The MRP family of drug efflux pumps

  2003cited by this paper
• Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats.

  2002cited by this paper
• Clinical Pharmacokinetics of Pravastatin

  2000cited by this paper
• Pharmacokinetic and Pharmacodynamic Evaluation for Tissue-Selective Inhibition of Cholesterol Synthesis by Pravastatin

  1998cited by this paper
• Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.

  1997cited by this paper
• Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.

  1996cited by this paper
• Immunol. Cell Biol.

  1995cited by this paper
• Cytochrome P450 changes in rats with streptozocin-induced diabetes

  1994cited by this paper
• Lipid peroxidation, glutathione levels and changes in glutathione‐related enzyme activities in streptozotocin‐induced diabetic rats

  1994cited by this paper
• Cytochrome P450 changes in rats with streptozocin-induced diabetes.

  1994cited by this paper
• Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys

  1992cited by this paper
• Metabolism of pravastatin sodium in isolated rat hepatocytes. I. Glutathione conjugate formation reaction.

  1992cited by this paper
• Gastroenterology.

  1976cited by this paper

• Potential Alteration of Statin-Related Pharmacological Features in Diabetes Mellitus

  2021cites this paper
• Interpretation of Drug Interaction Using Systemic and Local Tissue Exposure Changes

  2020influential citation
• Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance

  2020cites this paper
• Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?

  2018influential citation
• Recent advances in drug and nutrient transport across the blood-retinal barrier

  2018cites this paper
• The Obesogenic Potency of Various High-Caloric Diet Compositions in Male Rats, and Their Effects on Expression of Liver and Kidney Proteins Involved in Drug Elimination.

  2017cites this paper
• Physiological and pathophysiological factors affecting the expression and activity of the drug transporter MRP2 in intestine. Impact on its function as membrane barrier.

  2016cites this paper
• The Impact of Obesity on Proteins Involved in Drug Disposition

  2016cites this paper
• Altered Expression of Transporters, its Potential Mechanisms and Influences in the Liver of Rodent Models Associated with Diabetes Mellitus and Obesity

  2016cites this paper
• Intratracheal instillation of pravastatin for the treatment of murine allergic asthma: a lung-targeted approach to deliver statins

  2015cites this paper
• Functional Characterization of Carrier-Mediated Transport of Pravastatin across the Blood-Retinal Barrier in Rats

  2015cites this paper
• Co-administration of paroxetine increased the systemic exposure of pravastatin in diabetic rats due to the decrease in liver distribution

  2015influential citation
• Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure

  2014cites this paper
• Supplemental data : The hepatobiliary disposition of timosaponin B 2 is highly dependent on influx / efflux transporters but not metabolism

  2014cites this paper
• The Effect of Streptozotocin and Alloxan on the mRNA Expression of Rat Hepatic Transporters In Vivo

  2014cites this paper
• Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes

  2014cites this paper
• Microsoft Word-7305403-file00.docx

  2014cites this paper
• The impact of drug transporters on adverse drug reaction

  2013cites this paper
• Pregnancy Represses Induction of Efflux Transporters in Livers of Type I Diabetic Mice

  2013cites this paper
• Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin‐induced diabetic rats

  2012cites this paper
• Induction of multidrug resistance-associated protein 2 in liver, intestine and kidney of streptozotocin-induced diabetic rats

  2012cites this paper
• A Re-assessment of the Risk:Benefit Analysis of Statin Therapy during Pregnancy: Do Benefits of Treatment Outweigh Putative Reproductive Risks.

  2012cites this paper
• Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response

  2012cites this paper
• Effects of streptozotocin dosing on the disease state of streptozotocin-induced diabetic rats

  2011cites this paper
• Modélisation du mécanisme de diffusion d'une série de statines à travers la membrane cellulaire : approche biochromatographique et thermodynamique

  2010cites this paper